Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese
- PMID: 2375785
- DOI: 10.1016/0021-9150(90)90041-g
Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese
Abstract
The frequencies of the major apolipoprotein E(apo E) phenotypes in 65 normal, 426 hyperlipidemics, and 92 familial hypercholesterolemic Japanese subjects (FH) were studied, and features of hyperlipidemia compared between non-FH hyperlipidemia and FH. The frequencies of apo E phenotypes 3/3, 4/3, 3/2, 4/4 were almost the same in normal, non-FH hyperlipidemic, and FH subjects. The incidence of apo E7 was about 0.5% of total subjects. In type IV and V hyperlipidemias, incidence of E4/3 was higher than in any other hyperlipidemia. Incidence of E3/2 was also high in types III and V. In type II non-FH hyperlipidemia, incidence of E3/2 in type IIb was higher than in type IIa. VLDL-triglyceride, VLDL-cholesterol, apo C-II, apo C-III, and apo E levels were higher in E3/2 than in E3/3. But, in type IIa FH and type IIb FH, the incidence of E3/2 was the same, and lipid and apolipoprotein levels between 3/2 and 3/3 in FH were the same. These results indicate that allele epsilon 2 may be involved in the retention of VLDL or IDL, but not in FH.
Similar articles
-
Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.Horm Metab Res. 1990 Nov;22(11):589-94. doi: 10.1055/s-2007-1004980. Horm Metab Res. 1990. PMID: 2272605
-
Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.J Intern Med. 1991 Nov;230(5):397-405. doi: 10.1111/j.1365-2796.1991.tb00464.x. J Intern Med. 1991. PMID: 1940775 Clinical Trial.
-
Apolipoprotein E alleles and hyperlipoproteinemia in Japan.Clin Genet. 1988 Oct;34(4):246-51. doi: 10.1111/j.1399-0004.1988.tb02871.x. Clin Genet. 1988. PMID: 3233777
-
Familial defective apolipoprotein B-100.Dan Med Bull. 1998 Sep;45(4):370-82. Dan Med Bull. 1998. PMID: 9777289 Review.
-
Recent progress in the development of radioimmunoassays for human serum lipoproteins.Ann Clin Lab Sci. 1978 Mar-Apr;8(2):142-54. Ann Clin Lab Sci. 1978. PMID: 205163 Review.
Cited by
-
Genetic and molecular architecture of familial hypercholesterolemia.J Intern Med. 2023 Feb;293(2):144-165. doi: 10.1111/joim.13577. Epub 2022 Oct 17. J Intern Med. 2023. PMID: 36196022 Free PMC article. Review.
-
Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia.Front Cardiovasc Med. 2021 Apr 13;8:625852. doi: 10.3389/fcvm.2021.625852. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33928131 Free PMC article.
-
Polymorphisms of the apolipoprotein B and E genes and their relationship to plasma lipid variables in healthy Chinese men.Hum Genet. 1993 Sep;92(2):191-7. doi: 10.1007/BF00219691. Hum Genet. 1993. PMID: 8370587
-
[Apolipoprotein E polymorphism in the population of northern Morocco: frequency and effect on lipid parameters].Pan Afr Med J. 2013 Aug 31;15:157. doi: 10.11604/pamj.2013.15.157.2320. eCollection 2013. Pan Afr Med J. 2013. PMID: 24396563 Free PMC article. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous